Lewes, DE -- (SBWIRE) -- 09/06/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Inteliquent Inc(NASDAQ:IQNT), Allscripts Healthcare Solutions Inc(NASDAQ:MDRX), Vringo, Inc.(NASDAQ:VRNG), Trius Therapeutics, Inc.(NASDAQ:TSRX).
Inteliquent Inc(NASDAQ:IQNT) Trade complete the day at $8.56. The total number of shares changed hands during the day was 1.23 million. After opening at $8.43, the stock hit as high as $8.73. However, it traded between $2.10 and $11.30 over the last twelve months.
Inteliquent Inc, formerly Neutral Tandem, Inc., doing business as Inteliquent provides solutions for voice, data, and hosted services globally. With over 120 Ethernet sites across four continents, the Company is a global Ethernet interconnection provider, and has an Internet protocol version 6 (IPv6) network.
Can Investors Bet on IQNT after this News update? Find out in this Research Report
Allscripts Healthcare Solutions Inc(NASDAQ:MDRX) closed yesterday at $14.45. Around 1.23 million shares were traded, low from an-average trading volume of 1.88 million shares. The company is now valued at around $2.57 billion.
Allscripts Healthcare Solutions, Inc. (Allscripts) is a provider of clinical, financial, connectivity and information solutions and related professional services to hospitals, physicians and post-acute organizations
How Should Investors Trade MDRX Now? Don’t Miss out a Special Trend Analysis
Trius Therapeutics, Inc.(NASDAQ:TSRX) trade close at $13.68 and traded between $8.22 and $8.73 after opening the day at $8.43. Its performance over the last five days remained -0.07%, which stands at -0.58% for a month. Going back further than one month, 1-year performance after recent close was 186.19%.
Trius Therapeutics, Inc. operates as a biopharmaceutical research company. It has a cooperative research and development agreement with Lawrence Livermore National Security LLC for the research and development of gram-negative biodefense pathogens; and a license agreement with Dong-A Pharmaceutical Co., Ltd. to develop and sell Torezolid Phosphate outside of Korea.
What TSRX Charts Are Signaling for Traders? Find Out Here
Vringo, Inc.(NASDAQ:VRNG) trade close at $3.07. The stock is up around 6.97% this year and -2.54% for the last 12 months. Around 1.23 million shares changed hands yesterday, lower from an-average trading volume of 2.56 million shares.
Vringo, Inc., together with its subsidiaries, engages in the innovation, acquisition, licensing, and protection of intellectual property worldwide. Its intellectual property portfolio consists of approximately 500 patents and patent applications covering telecom infrastructure, Internet search, and mobile technologies.
Can VRNG Show a Strong Recovery? Find out in This Research Report
About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/